The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell ...

In this episode of the Ask the Expert video series, Simona Guidi, Associate Director, Cell and Gene Therapies at ProPharma, ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA ...

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...

By joining the network, NIBRT, Firefinch, and eg technology gain access to what EIT Health referred to as a pan-European ...

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 ...

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for ...

BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. as part ...